Wells Fargo & Company Avid Bioservices, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,920 shares of CDMO stock, worth $257,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,920

Previous 23,344 6.75%

Holding current value

$257,672

Previous $156,000 13.46%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.34 - $9.28 $9,991 - $14,625	1,576 Added 6.75%	24,920 $177,000
Q1 2024 May 10, 2024	BUY	$5.86 - $8.79 $15,728 - $23,592	2,684 Added 12.99%	23,344 $156,000
Q4 2023 Feb 09, 2024	SELL	$4.64 - $9.56 $146,916 - $302,698	-31,663 Reduced 60.51%	20,660 $134,000
Q3 2023 Nov 13, 2023	SELL	$9.4 - $14.04 $156,369 - $233,555	-16,635 Reduced 24.12%	52,323 $493,000
Q2 2023 Aug 15, 2023	BUY	$12.96 - $20.93 $248,935 - $402,023	19,208 Added 38.61%	68,958 $963,000
Q1 2023 May 12, 2023	BUY	$13.48 - $18.79 $569,947 - $794,459	42,281 Added 566.09%	49,750 $933,000
Q4 2022 Feb 13, 2023	SELL	$12.61 - $18.74 $42,785 - $63,584	-3,393 Reduced 31.24%	7,469 $102,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $3,771 - $5,008	-246 Reduced 2.21%	10,862 $208,000
Q2 2022 Aug 12, 2022	SELL	$11.63 - $21.55 $958,195 - $1.78 Million	-82,390 Reduced 88.12%	11,108 $170,000
Q1 2022 May 16, 2022	SELL	$16.63 - $27.73 $272,648 - $454,633	-16,395 Reduced 14.92%	93,498 $1.9 Million
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $5.13 Million - $8.47 Million	-247,832 Reduced 69.28%	109,893 $3.21 Million
Q3 2021 Nov 15, 2021	BUY	$19.05 - $28.32 $3.37 Million - $5.01 Million	177,040 Added 97.98%	357,725 $7.72 Million
Q2 2021 Aug 16, 2021	BUY	$18.93 - $25.65 $187,179 - $253,627	9,888 Added 5.79%	180,685 $4.63 Million
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $351,791 - $645,741	29,662 Added 21.02%	170,797 $3.11 Million
Q4 2020 Feb 09, 2021	BUY	$7.25 - $11.76 $6,648 - $10,783	917 Added 0.65%	141,135 $1.63 Million
Q3 2020 Nov 05, 2020	SELL	$6.53 - $8.6 $17,807 - $23,452	-2,727 Reduced 1.91%	140,218 $1.07 Million
Q2 2020 Aug 13, 2020	BUY	$4.11 - $6.78 $203,814 - $336,220	49,590 Added 53.12%	142,945 $937,000
Q1 2020 May 14, 2020	BUY	$3.15 - $7.39 $294,068 - $689,893	93,355 New	93,355 $477,000

Others Institutions Holding CDMO

# of Institutions

178

Shares Held

68.3M

Call Options Held

21.3K

Put Options Held

110K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $643M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Avid Bioservices, Inc. Transaction History